Home › IGA Glomerulonephritis › Pennsylvania
IGA Glomerulonephritis clinical trials in Pennsylvania
3 studies for IGA Glomerulonephritis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Penn Renal Electrolyte and Hypertension Perelman, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06935357Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Childrens Hospital of Philadelphia, Philadelphia
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.